Biotronik
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Biotronik sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Biotronik: 30 sponsored US clinical trials, 1 recruiting.
Biotronik sponsors 30 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 20 completed. 5 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bradycardia, with 2 trials.
Top-decile sponsor footprint
Biotronik ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
20 of 28 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (71.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
NCT07118358
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
NCT06540079
BIOTRONIK Conduction System Pacing With the Solia Lead
NCT05251363
Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System
NCT04870281
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
NCT04076917
Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy
NCT03884608
Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)
NCT03594266
QP ExCELs: MultiPole Pacing (MPP) Sub-Study
NCT03155724
Plexa ICD Lead Registry
NCT03103503
BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment
NCT02756338
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946
Protego DF4 Post Approval Registry
NCT02243696
ProMRI Study of the Iforia ICD System (Phase C)
NCT02096692
ProMRI Study of the Entovis Pacemaker System (Phase B)
NCT02009696
Safety and Performance Study of the Siello S Pacing Lead
NCT01791127
ProMRI Study of the Entovis Pacemaker System
NCT01761162
BIOHELIX-I Bare Metal Stent Study
NCT01612767
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
NCT01319812
Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)
NCT00836589
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
NCT00810264
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
NCT00683696
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
NCT00559988
REPLACE: Implantable Cardiac Pulse Generator Replacement Registry
NCT00395447
Interventricular Delay of Lumax HF-T for Heart Failure
NCT00508391
TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D
NCT00395642
COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring
NCT00396136
Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response
NCT00355797
TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up
NCT00336284
Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace
NCT00356057
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 4 | 5 |
What is open in the Biotronik pipeline
1 recruiting of 30 indexed (3% open); 20 completed (67%).
Phase mix: 5 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Bradycardia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Biotronik: open-pipeline peers nationwide
Peers matched on 30 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Biotronik sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
- Exact Sciences Corporation · 30 trials · 10% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Kyntra Bio · 3% recruiting · 30 trials
- New York State Psychiatric Institute · 3% recruiting · 364 trials
- Wills Eye · 3% recruiting · 59 trials
- SCRI Development Innovations · 3% recruiting · 146 trials
Related
What to do with this Biotronik page
30 registered trials is a research-attention snapshot, not an endorsement of Biotronik or any single study.
- 1 of Biotronik's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bradycardia is the condition Biotronik studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bradycardia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Biotronik pipeline card: 30 registered trials from official public datasets.Report a data error.